11:05 AM EDT, 05/24/2024 (MT Newswires) -- TriSalus Life Sciences ( TLSI ) on Friday said it has launched an exchange offer and consent solicitation relating to its warrants.
The company is offering warrant holders an opportunity to get 0.30 common share of the company for each warrant tendered. It is also concurrently soliciting consents from warrant holders to amend the warrant agreement in relation to the tender offer.
TriSalus said it intends to simplify the company's capital structure and reduce the potential dilutive impact of the warrants, and to enhance its financing flexibility.
Up to 4.3 million common shares of the company are being offered in exchange for the warrants, it said.
TriSalus Life Sciences ( TLSI ) fell 23% in recent trading.
Price: 7.35, Change: -2.19, Percent Change: -22.96